Evidence map›Paper›PMID 39217098›Full record

ArticleMetallomics : integrated biometal science2024

Stable potassium isotope ratios in human blood serum towards biomarker development in Alzheimer's disease.

Brandon Mahan, Yan Hu, Esther Lahoud, Mark Nestmeyer, Alex McCoy-West, Grace Manestar, Christopher Fowler, Ashley I Bush, Frédéric Moynier

Abstract read
In one paragraph

Article in Metallomics : integrated biometal science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Copper isotope shifts in biofluids track Alzheimer's pathology.Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brandon MahanMelbourne Analytical Geochemistry, School of Geography, Earth and Atmospheric Sciences, University of Melbourne, Melbourne, Australia.
Yan HuInstitut de Physique du Globe de Paris, Université Paris Cité, CNRS, 75238 Paris, France.
Esther LahoudInstitut de Physique du Globe de Paris, Université Paris Cité, CNRS, 75238 Paris, France.ORCID 0009-0007-3009-3235
Mark NestmeyerIsoTropics Geochemistry Lab, Earth and Environmental Science, James Cook University, Townsville, Queensland 4814, Australia.
Alex McCoy-WestIsoTropics Geochemistry Lab, Earth and Environmental Science, James Cook University, Townsville, Queensland 4814, Australia.
Grace ManestarMelbourne Analytical Geochemistry, School of Geography, Earth and Atmospheric Sciences, University of Melbourne, Melbourne, Australia.
Christopher FowlerThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Ashley I BushThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Frédéric MoynierInstitut de Physique du Globe de Paris, Université Paris Cité, CNRS, 75238 Paris, France.ORCID 0000-0003-4321-5581

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Alzheimer's disease (AD)-affected brain purges K with concurrently increasing serum K, suggesting brain-blood K transferal. Here, natural stable K isotope ratios-δ41K-of human serum samples were characterized in an AD biomarker pilot study (plus two paired Li-heparin and potassium ethylenediaminetetraacetic acid [K-EDTA] plasma samples). AD serum was found to have a significantly lower mean δ41K relative to controls. To mechanistically explore this change, novel ab initio calculations (density functional theory) of relative K isotope compositions between hydrated K+ and organically bound K were performed, identifying hydrated K+ as isotopically light (lower δ41K) compared to organically bound K. Taken together with literature, serum δ41K and density functional theory results are consistent with efflux of hydrated K+ from the brain to the bloodstream, manifesting a measurable decrease in serum δ41K. These data introduce serum δ41K for further investigation as a minimally invasive AD biomarker, with cost, scalability, and stability advantages over current techniques.

Indexed as

Alzheimer DiseaseBiomarkersPotassiumAgedAged, 80 and overFemaleHumansIsotopesMaleMiddle AgedPilot ProjectsBiomarkersIsotopesPotassiumAlzheimer's diseasebiomarkerisotopemetallomicspotassium

Identifiers

PMID39217098
PMCPMC11411773

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.